Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,683 | 142 | 82.2% |
| Consulting Fee | $1,004 | 3 | 14.5% |
| Education | $164.56 | 8 | 2.4% |
| Travel and Lodging | $58.00 | 1 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $2,196 | 19 | $0 (2022) |
| Medtronic Vascular, Inc. | $587.93 | 6 | $0 (2020) |
| Amgen Inc. | $545.39 | 20 | $0 (2023) |
| ABIOMED | $530.56 | 8 | $0 (2020) |
| Edwards Lifesciences Corporation | $494.51 | 4 | $0 (2024) |
| PFIZER INC. | $484.92 | 25 | $0 (2024) |
| Eli Lilly and Company | $291.05 | 7 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $214.05 | 11 | $0 (2018) |
| Impulse Dynamics (USA) Inc. | $181.58 | 2 | $0 (2022) |
| Philips Electronics North America Corporation | $163.89 | 3 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $753.30 | 16 | Eli Lilly and Company ($291.05) |
| 2023 | $333.36 | 16 | Amgen Inc. ($152.57) |
| 2022 | $463.52 | 18 | Impulse Dynamics (USA) Inc. ($112.33) |
| 2021 | $479.32 | 9 | Abbott Laboratories ($258.40) |
| 2020 | $526.49 | 9 | Abbott Laboratories ($260.00) |
| 2019 | $857.98 | 25 | ABIOMED ($308.05) |
| 2018 | $1,520 | 27 | Abbott Laboratories ($398.04) |
| 2017 | $1,975 | 34 | Abbott Laboratories ($1,132) |
All Payment Transactions
154 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/06/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $20.91 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/06/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $17.49 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/30/2024 | Recor Medical Inc | PARADISE RENAL DENERVATION SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $120.86 | General |
| Category: Endovascular | ||||||
| 10/02/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $18.73 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/26/2024 | Eli Lilly and Company | — | Food and Beverage | Cash or cash equivalent | $65.03 | General |
| 06/26/2024 | Eli Lilly and Company | — | Travel and Lodging | Cash or cash equivalent | $58.00 | General |
| 06/12/2024 | Edwards Lifesciences Corporation | Edwards SAPIEN 3 Ultra Transcatheter Heart Valve (Device) | Food and Beverage | In-kind items and services | $162.97 | General |
| Category: Transcatheter Heart Valves | ||||||
| 05/30/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $24.48 | General |
| 04/05/2024 | Eli Lilly and Company | — | Food and Beverage | In-kind items and services | $86.67 | General |
| 04/05/2024 | Eli Lilly and Company | — | Food and Beverage | In-kind items and services | $45.41 | General |
| 04/05/2024 | Eli Lilly and Company | — | Food and Beverage | In-kind items and services | $22.87 | General |
| 04/05/2024 | Eli Lilly and Company | — | Food and Beverage | In-kind items and services | $7.62 | General |
| 04/05/2024 | Eli Lilly and Company | — | Food and Beverage | In-kind items and services | $5.45 | General |
| 02/06/2024 | Novo Nordisk Inc | — | Education | In-kind items and services | $32.27 | General |
| 02/06/2024 | Novo Nordisk Inc | — | Education | In-kind items and services | $32.27 | General |
| 02/06/2024 | Novo Nordisk Inc | — | Education | In-kind items and services | $32.27 | General |
| 11/10/2023 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $17.71 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/15/2023 | Philips Electronics North America Corporation | (5044) MCOT (Device) | Food and Beverage | Cash or cash equivalent | $20.87 | General |
| Category: Medical Device | ||||||
| 08/04/2023 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $1.75 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/13/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $16.62 | General |
| Category: Diabetes | ||||||
| 04/25/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $27.72 | General |
| Category: DIABETES | ||||||
| 04/21/2023 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $12.71 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 04/11/2023 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $15.61 | General |
| Category: Cardiovascular | ||||||
| 04/03/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $123.93 | General |
| Category: Cardiology | ||||||
| 02/28/2023 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $17.99 | General |
| Category: Cardiovascular | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 158 | 223 | $50,444 | $11,846 |
| 2022 | 7 | 217 | 275 | $58,185 | $17,037 |
| 2021 | 7 | 181 | 256 | $57,385 | $20,139 |
| 2020 | 6 | 175 | 234 | $58,696 | $16,748 |
All Medicare Procedures & Services
31 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 79 | 126 | $25,830 | $5,874 | 22.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 37 | 48 | $13,916 | $2,841 | 20.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 15 | 15 | $5,700 | $1,376 | 24.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 16 | 17 | $3,485 | $1,071 | 30.7% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 11 | 17 | $1,513 | $683.57 | 45.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 65 | 95 | $18,371 | $4,812 | 26.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 47 | 54 | $14,137 | $4,017 | 28.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 25 | 37 | $7,104 | $2,467 | 34.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 18 | 18 | $6,428 | $1,939 | 30.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 11 | 11 | $5,264 | $1,597 | 30.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 11 | 12 | $3,036 | $1,056 | 34.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 11 | 12 | $1,974 | $685.26 | 34.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Facility | 2022 | 12 | 13 | $1,434 | $316.10 | 22.0% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 17 | 23 | $437.00 | $148.34 | 33.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 34 | 54 | $13,284 | $4,940 | 37.2% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 27 | 42 | $10,038 | $3,526 | 35.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 28 | 37 | $6,216 | $2,427 | 39.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 24 | 41 | $6,847 | $2,397 | 35.0% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 11 | 11 | $5,181 | $1,632 | 31.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 20 | 29 | $4,872 | $1,522 | 31.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 14 | 19 | $4,674 | $1,475 | 31.6% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 11 | 11 | $3,465 | $1,221 | 35.2% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2021 | 12 | 12 | $2,808 | $998.88 | 35.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 39 | 66 | $16,236 | $5,274 | 32.5% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 31 | 52 | $12,653 | $4,382 | 34.6% |
About Dr. Frank Smart, MD
Dr. Frank Smart, MD is a Cardiovascular Disease healthcare provider based in New Orleans, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/02/2006. The National Provider Identifier (NPI) number assigned to this provider is 1275571341.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Frank Smart, MD has received a total of $6,909 in payments from pharmaceutical and medical device companies, with $753.30 received in 2024. These payments were reported across 154 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($5,683).
As a Medicare-enrolled provider, Smart has provided services to 731 Medicare beneficiaries, totaling 988 services with total Medicare billing of $65,770. Data is available for 4 years (2020–2023), covering 31 distinct procedure/service records.
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Cardiovascular Disease, Advanced Heart Failure and Transplant Cardiology
- Location New Orleans, LA
- Active Since 06/02/2006
- Last Updated 03/17/2018
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1275571341
Products in Payments
- CardioMEMS HF System (Device) $1,399
- Impella (Device) $530.56
- Resolute (Device) $477.95
- Repatha (Biological) $451.37
- Assurity Pacemaker (Device) $308.40
- ENTRESTO (Drug) $214.05
- HeartMate (Device) $166.36
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve (Device) $162.97
- ELIQUIS (Drug) $143.66
- LifeVest (Device) $130.92
- PARADISE RENAL DENERVATION SYSTEM (Device) $120.86
- CRT-Ds (Device) $118.46
- VYNDAQEL (Drug) $116.17
- ACTHAR (Biological) $115.72
- Optimizer (Device) $112.33
- Stellarex Long (Device) $111.38
- Corlanor (Drug) $90.02
- Edwards SAPIEN 3 Transcatheter Heart Valve (Device) $89.96
- JARDIANCE (Drug) $71.61
- Optimizer Smart System (Device) $69.25
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in New Orleans
Rajan Patel, M.d, M.D
Cardiovascular Disease — Payments: $545,798
Carl Lavie, Md, MD
Cardiovascular Disease — Payments: $365,115
Clement Eiswirth, Md, MD
Cardiovascular Disease — Payments: $362,313
James Jenkins, Md, MD
Cardiovascular Disease — Payments: $319,286
Sammy Khatib, M.d, M.D
Cardiovascular Disease — Payments: $168,538
Stephen Ramee, Md, MD
Cardiovascular Disease — Payments: $80,095